Gossamer Bio Inc – Company Profile Gossamer Bio Inc – Company Profile

Gossamer Bio Inc (Gossamer) is a clinical-stage biopharmaceutical company that discovers, acquires, develops and commercializes therapeutics in the disease areas of immunology, inflammation and oncology. The company’s product portfolio includes GB002, for pulmonary arterial hypertension, GB5121 for adult patients with relapsed/refractory CNS lymphoma and GB7208 for multiple sclerosis. Gossamer operates un the US and Ireland. Gossamer is headquartered in San Diego, California, the US.